Methods for detecting a biomarker by alternating current electrokinetics
View Patent ↗Methods are described for detecting pathogens, infectious diseases, and physiological conditions by quantifying change of impedance over time of when a biological sample is applied onto a lab-on-a-chip. The lab-on-a-chip utilizes alternating-current electrokinetic (ACEK) phenomena such that molecules move or are carried in an electric field generated by the application of an electrical signal of predetermined magnitude and frequency to an electrode array of the lab-on-a-chip.
1. A method for detecting a biomarker in a sample, comprising:
functionalizing an electrode array by coating the electrode array with a coating material, the electrode array comprising a plurality of electrodes;
applying the sample onto the electrode array;
controlling, using a controller, an impedance read-out circuit to measure an initial value of an impedance of the electrode array when the sample is initially applied;
controlling, using a controller, a signal generator coupled to the electrode array to generate an electrical signal and apply the electrical signal to the electrode array after the initial value of the impedance is measured, the electrical signal having a fixed magnitude and a fixed frequency;
controlling, using the controller, the impedance read-out circuit to measure the impedance versus time of the electrode array for a predetermined period of time after the initial value of the impedance is measured; and
calculating a change in the impedance versus time of the electrode array with respect to the initial value of the impedance.
2. The method of claim 1 , further comprising, when the change in the impedance of the electrode array exceeds a predetermined threshold, indicating the presence of a disease or a condition.
3. The method of claim 1 , further comprising, when the change in the impedance of the electrode array exceeds a predetermined threshold, indicating the presence of one of the following: Johne's disease, mastitis, pregnancy, tuberculosis, clotting, heart attack, influenza and diabetes.
4. The method of claim 1 , wherein the coating material comprises a molecule that binds to the biomarker.
5. The method of claim 1 , wherein the coating material comprises a molecule that reacts with the biomarker.
6. The method of claim 1 , wherein the coating material comprises one or more of an antigen, an antibody, a protein, a peptide, a nucleic acid, a lipid, and an enzyme.
7. The method of claim 1 , wherein the biomarker is one or more of an antigen, an antibody, a protein, a peptide, a nucleic acid, a hormone, a lipid, a sugar, and a probe molecule.
8. The method of claim 1 , further comprising, prior to applying the sample onto the electrode array:
mixing the sample with a predetermined concentration of labeling particles, the labeling particles being functionalized with linker molecules specific to the biomarker; and
incubating the mixture of the sample and the labeling particles.
9. The method of claim 8 , wherein the labeling particles is one of latex beads, magnetic beads, and microorganisms.
10. The method of claim 1 , further comprising, prior to functionalizing the electrode array, coating the electrode array with a pre-coating material.
11. The method of claim 10 , wherein the pre-coating material is 3-aminopropyl-triethoxysilane or polypyrrole.
12. The method of claim 1 , wherein the electrical signal is a voltage signal having a magnitude less than 10 Vrms and a frequency less than 10 MHz.
13. The method of claim 1 , wherein the electrode array is provided in an integrated circuit.
14. The method of claim 1 , wherein the predetermined period of time is less than 10 minutes.
15. The method of claim 1 , wherein the sample is applied to the electrode array only once.
16. The method of claim 1 , wherein the electrode array is a coplanar electrode array.
17. The method of claim 1 , wherein the plurality of electrodes in the electrode array are parallel plate electrodes.